Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: May 2022 (Filing Date: May 20, 2022)
Principal Executive Office: Herstal, Belgium
This filing serves to furnish a press release issued by the Company on May 19, 2022, attached as Exhibit 99.1. The filing explicitly states that the information contained in the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not disclose specific material changes in financial performance or operations. The document solely references the issuance of a press release on May 19, 2022, without summarizing its content.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It notes that the attached press release is furnished for informational purposes but does not detail the substance of that release.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated May 19, 2022) to understand the specific event or announcement triggering this filing.
- Verify if the press release contains material non-public information or updates to financial guidance not detailed in this summary.
- Confirm the legal status of the information, noting the disclaimer that the press release is not "filed" under the Exchange Act.